POX Range and the Threshold for Screening Major CHD in Neonates at Different Altitudes
Study on the Normal Range of Pulse Oximetry and the Threshold for Screening Critical Congenital Heart Disease in Neonates at Different Altitudes in China
1 other identifier
observational
2,200
1 country
8
Brief Summary
major CHD (Congenital Heart Disease) screening by POX (pulse oximetry) in sea-level areas is not fit for low, medium and high altitude areas, but the normal range of pulse oximetry at different altitude areas has not been studied before, so the current screening technology can only be used in sea-level areas, but not for newborns in low, medium and high altitude areas. We need to carry out a research to clarify the range of POX and make sure the threshold of POX in major CHD screening in different altitude areas of China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2019
CompletedFirst Posted
Study publicly available on registry
January 23, 2020
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2021
CompletedJuly 28, 2021
December 1, 2020
1.2 years
November 26, 2019
July 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulse oximetry of healthy newborns at 6th hour after birth at different altitudes
Pulse oximetry of healthy newborns at 6th hour after birth would be measured by monitor at 6th hour after birth and would be described by range interquartile in healthy neonates in hospitals with different altitudes. Altitude levels :sea level, within 1000 meters above sea level, 1000 to 2000 meters above sea level, 2000 to 3000 meters above sea level, 3000 to 4000 meters above sea level and 4000 to 5000 meters above sea level.
At 6th hours after birth
Secondary Outcomes (9)
Pulse oximetry of healthy newborns at 12th hour after birth at different altitudes
At 12th hours after birth
Pulse oximetry of healthy newborns at 24th hour after birth at different altitudes
At 24th hours after birth
Pulse oximetry of healthy newborns at 48th hour after birth at different altitudes
At 48th hours after birth
Pulse oximetry of healthy newborns at 72th hour after birth at different altitudes
At 72th hours after birth
Pulse oximetry of newborns with critical congenital heart disease at 6th hour after birth at different altitudes
At 6th hours after birth
- +4 more secondary outcomes
Study Arms (6)
sea level
Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center of sea level were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.
altitude <1000
Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude less than 1000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.
altitude 1000-2000
Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude between 1000-2000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.
altitude 2000-3000
Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude between 2000-3000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.
altitude 3000-4000
Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude between 3000-4000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.
altitude 4000-5000
Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude between 4000-5000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.
Interventions
it's only observational study. No interventions.
Eligibility Criteria
During the study period (January 15, 2019 to December 15, 2020), all newborns in continuous delivery were included simultaneously in various medical centers in different altitude areas. For major CHD infants, the study period will be January 15, 2019 to December 15, 2020.
You may qualify if:
- For healthy newborns:
- Healthy, asymptomatic, singleton term infants (37-41 weeks gestation);
- Appropriate for gestational age (using the international WHO's intrauterine growth curve to evaluate);
- Only newborns with Apgar score ≥ 7 in 1 minute and 5 minutes were selected;
- There is no known congenital heart disease based on the ECHO result , no murmur, no obvious signs (no fever, no tachycardia or respiratory symptoms at the time of admission).
- For major CHD newborns:
- Echocardiography clearly diagnosed the following congenital heart diseases: Aortic stenosis, Double outlet of right ventricle, Ebstein's malformation, Left cardiac hypoplasia syndrome, Aortic arch disconnection, Pulmonary atresia, Single ventricle, Tetralogy of Fallot, Complete anomalous pulmonary venous drainage, Transposition of great arteries, Tricuspid valve atresia, and Single trunk of arteries and other major CHD based on Ewer's denition.
You may not qualify if:
- For healthy newborns:
- Newborn with caesarean section; newborn with smoking mother; newborn with definite congenital heart disease before discharge.
- For major CHD newborns:
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital of Fudan Universitylead
- Hainan women and children medical centercollaborator
- People's Hospital of Xinjiang Uygur Autonomous Regioncollaborator
- Yan'an Affiliated Hospital of Kunming Medical Universitycollaborator
- Qinghai Red Cross Hospitalcollaborator
- Tibet Autonomous Region People's Hospitalcollaborator
- People's Hospital of Golog Tibetan Autonomous Prefecturecollaborator
- People's Hospital of Naqu District, Tibetcollaborator
- People's Hospital of Luchun County, Yunnan Provincecollaborator
Study Sites (8)
People's Hospital of Golog Tibetan Autonomous Prefecture
Guoluo Prefecture, China
Hainan women and children medical center
Haikou, China
Yan'an Hospital Affiliated to Kunming Medical University
Kunming, China
Tibet Autonomous People's Hospital
Lhasa, China
People's Hospital of Luchun County, Yunnan Province
Luchun, China
People's Hospital of Naqu District, Tibet
Naqu, China
Qinghai Red Cross Hospital
Qinghai, China
People's Hospital of Xinjiang Uygur Autonomous Region
Ürümqi, China
Study Officials
- STUDY CHAIR
Weili Yan, PhD
Epidemiology Office of Children's hospital of Fudan University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2019
First Posted
January 23, 2020
Study Start
February 1, 2020
Primary Completion
April 15, 2021
Study Completion
April 15, 2021
Last Updated
July 28, 2021
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share